Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Shareholders Equity (Quarterly) : 121.75M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.75M |
| March 31, 2026 | 127.36M |
| December 31, 2025 | 129.38M |
| September 30, 2025 | 3.212M |
| June 30, 2025 | 2.62M |
| March 31, 2025 | 5.331M |
| December 31, 2024 | 7.492M |
| September 30, 2024 | 6.608M |
| June 30, 2024 | 9.949M |
| March 31, 2024 | 10.06M |
| December 31, 2023 | 11.31M |
| September 30, 2023 | 14.08M |
| June 30, 2023 | 15.80M |
| March 31, 2023 | 13.75M |
| December 31, 2022 | 12.48M |
| September 30, 2022 | 12.43M |
| June 30, 2022 | 4.211M |
| March 31, 2022 | 4.792M |
| December 31, 2021 | 7.365M |
| September 30, 2021 | 3.92M |
| June 30, 2021 | -9.444M |
| March 31, 2021 | 7.729M |
| December 31, 2020 | -7.099M |
| September 30, 2020 | 14.12M |
| June 30, 2020 | 16.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.978M |
| December 31, 2019 | 5.126M |
| September 30, 2019 | 7.043M |
| June 30, 2019 | 1.963M |
| March 31, 2019 | 3.272M |
| December 31, 2018 | 6.050M |
| September 30, 2018 | 4.479M |
| June 30, 2018 | 6.175M |
| March 31, 2018 | 6.607M |
| December 31, 2017 | 8.515M |
| September 30, 2017 | 11.56M |
| June 30, 2017 | 7.693M |
| March 31, 2017 | 9.780M |
| December 31, 2016 | 11.33M |
| September 30, 2016 | -3.785M |
| June 30, 2016 | 0.8365M |
| March 31, 2016 | -0.1694M |
| December 31, 2015 | 4.967M |
| September 30, 2015 | 8.903M |
| June 30, 2015 | 14.54M |
| March 31, 2015 | 19.36M |
| December 31, 2014 | 17.72M |
| September 30, 2014 | 20.90M |
| June 30, 2014 | 24.03M |
| March 31, 2014 | 26.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.32M |
| Total Liabilities (Quarterly) | 5.567M |
| Current Ratio | 24.25 |
| Net Debt Paydown Yield | 0.00% |